BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7321526)

  • 1. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
    Raine CS; Scheinberg L; Waltz JM
    Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS; Moore GR; Hintzen R; Traugott U
    Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
    Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of oligodendrocytes in chronic relapsing experimental autoimmune encephalomyelitis.
    Moore GR; Traugott U; Raine CS
    J Neurol Sci; 1984 Aug; 65(2):137-45. PubMed ID: 6481396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
    Chang A; Tourtellotte WW; Rudick R; Trapp BD
    N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
    Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autoradiographic study of cellular proliferation in remyelination of the central nervous system.
    Ludwin SK
    Am J Pathol; 1979 Jun; 95(3):683-96. PubMed ID: 453329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions.
    Wu E; Raine CS
    Lab Invest; 1992 Jul; 67(1):88-99. PubMed ID: 1625450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendrocytes and the early multiple sclerosis lesion.
    Prineas JW; Parratt JD
    Ann Neurol; 2012 Jul; 72(1):18-31. PubMed ID: 22829266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Cho ES; Sharer LR
    Lab Invest; 1990 Nov; 63(5):624-36. PubMed ID: 1700195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: remyelination in acute lesions.
    Raine CS; Wu E
    J Neuropathol Exp Neurol; 1993 May; 52(3):199-204. PubMed ID: 7684075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
    Raine CS; Wu E; Ivanyi J; Katz D; Brosnan CF
    Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.